Average Co-Inventor Count = 3.80
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Andrx Pharmaceuticals, Inc. (13 from 57 patents)
2. Watson Pharmaceuticals, Inc. (5 from 27 patents)
3. Other (2 from 832,761 patents)
4. Takeda Pharmaceutical Company Limited (2 from 1,178 patents)
5. Actavis, Inc. (2 from 4 patents)
6. Andrx Labs, LLC (1 from 10 patents)
7. Andrx Corporation, Inc. (1 from 8 patents)
24 patents:
1. 9060941 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
2. 8747898 - Controlled release oral dosage form
3. 8668932 - Extended release venlafaxine formulation
4. 8668931 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
5. 8628797 - Oral extended-release composition
6. 8545880 - Controlled release oral dosage form
7. 8529946 - Rapidly disintegrating antihistamine formulation
8. 8470368 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
9. 8309125 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10. 8084058 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
11. 7959946 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
12. 7931915 - Extended release venlafaxine formulation
13. 7790200 - Formulation and process for drug loaded cores
14. 7785627 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
15. 7771750 - Controlled release oral dosage form